1Mooser V, Nussberger J,Juillerat L, et al. Reactive hyper reninemia is a major determinant of plasma angiotensin Ⅱ during ACE inhibition[J]. J Cardiovasc Pharmacol,2004,15 276 - 282.
2Chobanian AV, Bakris GL, Black HR, et al. Roceelta EJ and the national high blood pressure education program coordinating committee. The seventh report of the joint national committee oil the prevention, detection, evaluation and treament of high blood pressure[J]. Hypertension, 2003,42:1206 - 1252.
3Unger T. Neurohormonal modulation in cardiovascular disease [J]. Am Heart J,2000,139:2- 8.
1[1]Unger T. Neurohormonal modulation in cardiovascular disease. Am Heart J, 2000, 139:2-8.
2[2]Lijnen P, Petrov V. Renin-angiotensin system, hypertrophy and gene expression in cardiac myocytes. J Mol Cell Cardiol, 1999, 31: 949-970.
3[3]Wei C C, Meng Q C, Palmer R, et al. Evidence for angiotensin converting enzyme and chymase mediated angiotensin Ⅱ formation in the interstitial fluid space of the dog heart in vivo. Circulation, 1999, 99: 2583-2589.
4[4]Mooser V, Nussberger J, Juillerat L, et al. Reactive hyperreninemia is a major determinant of plasma angiotensin Ⅱ during ACE inhibition. J Cardiovasc Pharmacol, 1990, 15: 276-282.
5[5]Jalowy A, Szhulz R, Dorge H, et al. Infarct size reduction by AT1-receptor blockade through a signal cascade of AT2-receptor activation, bradykininand prostaglandins in pigs. J Am Coll Cardiol, 1998, 32: 1787-1796.
6[6]Siragy H M, Carey R M. The subtype 2 angiotensin receptor mediates renal production of nitric oxide in conscious rats. J Clin Invest, 1997,325:449-454.
7[7]Krombach R S, Clair M J, Hendrick J W, et al. Angiotensin converting enzyme inhibition, AT1 receptor inhibition, and combination therapy with pacing induced heart failure: Effects on left ventricular performance and regional blood flow patterns. Cardiovasc Res, 1998, 38: 631-645.
8[8]Spinale F G, de Gasparo M, Whitebread S, et al.Modulation of the renin-angiotensin pathway through enzyme inhibition and specific receptor blockade in pacing-induced heart failure: I. Effects on left ventricular performance and neurohormonal systems. Circulation, 1997, 96: 2385-2396.
9[9]Kim S, Zhan Y, Izumi Y, et al. Cardiovascular effects of combination of perindopril, candesartan, and amlodipine in hypertensive rats. Hypertension, 2000, 35: 769-774.
10[10]Kim S, Yoshiyama M, Izumi Y, et al. Effects of combination of ACE inhibitor and angiotensin receptor blocker on cardiac remodeling, cardiac function, and survival in rat heart failure. Circulation, 2001, 103: 148-154.
